PUBLISHER: The Business Research Company | PRODUCT CODE: 2106471
PUBLISHER: The Business Research Company | PRODUCT CODE: 2106471
Reversed phase columns are chromatographic columns that utilize a non-polar (hydrophobic) stationary phase together with a comparatively polar mobile phase, enabling compound separation through hydrophobic interactions. They are widely employed in liquid chromatography for separating substances according to their polarity, with compounds exhibiting greater non-polar characteristics remaining retained within the column for longer durations.
The primary product categories of reversed phase columns consist of octyl silica columns, butyl silica columns, phenyl columns, and cyano columns. The primary octyl silica columns are chromatographic separation columns utilized for isolating moderately nonpolar chemical compounds in analytical and laboratory-based operations. The primary construction of these columns involves material variants such as silica gel-based columns, polymer-based columns, and composite-type columns. The primary development of these columns incorporates particle engineering technologies including fully porous particles, core-shell superficially porous particles, and monolithic column structures, and they are utilized by end-use sectors such as pharmaceutical and biotechnology companies, contract research organizations, academic and scientific research institutes, food testing laboratories, environmental monitoring agencies, and hospitals along with clinical diagnostic laboratories.
Tariffs are influencing the reversed phase columns market by increasing costs of imported silica materials, specialty polymers, chromatography media, precision manufacturing equipment, and analytical laboratory components essential for column fabrication. This is elevating production expenditures and impacting the availability of advanced chromatography solutions, especially in regions that rely heavily on imported laboratory supplies such as Asia-Pacific and Europe. Segments including phenyl columns, cyano columns, and core-shell superficially porous particle columns, along with pharmaceutical and biotechnology applications, are most impacted due to dependence on global supply chains. However, tariffs are simultaneously promoting domestic production, diversification of regional suppliers, and heightened investment in local analytical instrumentation and chromatography infrastructure, fostering long-term market resilience.
The reversed phase columns market size has grown strongly in recent years. It will grow from $1.56 billion in 2025 to $1.69 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to expansion of pharmaceutical research activities, increasing adoption of liquid chromatography techniques, growth in analytical testing laboratories, rising demand for drug quality assurance, and advancements in chromatographic separation technologies.
The reversed phase columns market size is expected to see strong growth in the next few years. It will grow to $2.35 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth during the forecast period can be linked to expanding biologics and biosimilars development activities, rising demand for high-throughput analytical workflows, increasing focus on precision-based analytical testing, broader application of environmental and food safety testing regulations, and growing investment in advanced chromatography consumables. Key trends expected in the forecast period include increasing demand for high-purity reversed-phase chromatography columns, growing adoption of core-shell particle technology to improve separation efficiency, rising use of reversed-phase columns in pharmaceutical quality control, expansion of application-specific chromatography columns for complex sample analysis, and development of high-stability and long-lasting column materials.
The growing emphasis on biologics is expected to drive the growth of the reversed phase columns market going forward. Biologics are therapeutic products derived from living organisms or their components that target specific immune pathways to treat diseases. The focus on biologics is increasing due to advancements in biotechnology and immunology, which have enabled the development of more precise and effective therapies that address the underlying causes of immune-mediated diseases rather than only managing symptoms. Reversed phase columns support biologics analysis by providing high-resolution separation and detailed characterization of complex biomolecules, thereby improving purity assessment, structural evaluation, and quality control throughout biopharmaceutical development and manufacturing. For instance, in February 2025, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, the 2023 WHO Essential Medicines List includes 81 biologic therapies, representing over 15% of all listed medicines. Therefore, the growing emphasis on biologics is driving the growth of the reversed phase columns market.
Leading companies operating in the reversed phase columns market are focusing on developing innovative solutions, such as novel chromatography columns, to enhance separation efficiency, improve resolution and selectivity, and enable faster, more accurate, and higher-throughput analytical workflows. Novel chromatography columns are advanced separation tools designed with improved stationary phases and technologies to deliver higher resolution, faster analysis, and better selectivity compared to traditional columns. For example, in March 2024, Phenomenex, a US-based chromatography solutions provider, launched Biozen Native RP-1 and RP-5, an innovative reversed-phase column technology for advanced biopharmaceutical characterization. These columns are engineered with bioinert surfaces to minimize non-specific binding, improving peak shape and recovery of sensitive biomolecules such as monoclonal antibodies and ADCs. They utilize optimized stationary phase chemistries (RP-1 and RP-5 selectivities) to enable complementary separations, enhancing impurity profiling and structural characterization. The platform delivers high-throughput performance with improved efficiency and reproducibility compared to conventional reversed-phase columns, making it suitable for complex biologics, ADC payload analysis, and native-state protein separations.
In December 2025, Romer Industries Holding GmbH, a Germany-based manufacturing company, acquired VDS optilab Chromatographietechnik GmbH for an undisclosed value. Through this acquisition, Romer Industries Holding GmbH aims to strengthen its presence in the analytical instrumentation and chromatography sector by broadening its product portfolio and enhancing its capabilities in high-precision separation technologies used in pharmaceutical and bioanalytical applications. VDS optilab Chromatographietechnik GmbH is a Germany-based company that offers a broad range of reversed-phase (RP) chromatography columns.
Major companies operating in the reversed phase columns market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Waters Corporation, Merck KGaA, Phenomenex Inc., Shimadzu Corporation, Tosoh Corporation, YMC Co. Ltd., Osaka Soda Co. Ltd., Daicel Corporation, Biotage AB, GL Sciences Inc., Restek Corporation, Hamilton Company, KNAUER Wissenschaftliche Gerate GmbH, SiliCycle Inc., Dikma Technologies Inc., Yamazen Corporation, Imtakt Corporation, Sepax Technologies Inc., Orochem Technologies Inc., MicroSolv Technology Corporation
North America was the dominant region in the reversed phase columns market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in reversed phase columns report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the reversed phase columns market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The reversed phase columns market consists of sales of polar-embedded reversed-phase columns, aqueous-compatible (AQ) columns, polymer-based reversed-phase columns, and monolithic silica columns. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The reversed phase columns market research report is one of a series of new reports from The Business Research Company that provides reversed phase columns market statistics, including reversed phase columns industry global market size, regional shares, competitors with a reversed phase columns market share, detailed reversed phase columns market segments, market trends and opportunities, and any further data you may need to thrive in the reversed phase columns industry. This reversed phase columns market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Reversed Phase Columns Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses reversed phase columns market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for reversed phase columns ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The reversed phase columns market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.